EICHOR
● Completed
A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis
Condition: Moderate to Severe Ulcerative Colitis · Sponsor: Hoffmann-La Roche
About this study
This phase 2b study is designed to have all subjects go into a 12 week induction period to compare different doses of study drug against placebo. After induction is complete all subjects will receive active therapy for 40 weeks, followed by a 12 week follow up period.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (166)
| Digestive Health Specialists | Dothan, Alabama, United States | — |
| Dothan Surgery Center | Dothan, Alabama, United States | — |
| Flowers Hospital | Dothan, Alabama, United States | — |
| Lynn Institute of the Ozarks | Little Rock, Arkansas, United States | — |
| Surinder Saini, M.D., Inc. | Newport Beach, California, United States | — |
| Endoscopy Center of Connecticut, LLC | Guilford, Connecticut, United States | — |
| Endoscopy Center of Connecticut, LLC | Hamden, Connecticut, United States | — |
| Medical Research Center Of Connecticut, LLC | Hamden, Connecticut, United States | — |
| PACT Gastroenterology Center | Hamden, Connecticut, United States | — |
| Whitney Imaging | Hamden, Connecticut, United States | — |
| Medycal Research Inc. | Brooksville, Florida, United States | — |
| Safety Harbor Surgery | Clearwater, Florida, United States | — |
+ 154 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04090411